Financhill
Buy
53

MEDP Quote, Financials, Valuation and Earnings

Last price:
$549.22
Seasonality move :
3.24%
Day range:
$541.02 - $552.60
52-week range:
$250.05 - $626.26
Dividend yield:
0%
P/E ratio:
38.41x
P/S ratio:
7.05x
P/B ratio:
52.68x
Volume:
216.9K
Avg. volume:
279.6K
1-year change:
56.67%
Market cap:
$15.5B
Revenue:
$2.1B
EPS (TTM):
$14.30

MEDP Analysts' Consensus Rating

The 12 analysts providing 12-month price projections for Medpace Holdings, Inc. shares anticipate an average target of $538.58, ranging from a low estimate of $329.00 to a high estimate of $655.00. This average target implies a growth of -1.93% compared to the current stock price of $549.17.

Consensus Price Target

$538.58

Highest Price Target

$655.00

Lowest Price Target

$329.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 2 1 1

Hold 11 8 8

Sell 0 3 3
Consensus Hold Hold Hold

MEDP Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is up 102.52% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is up 41.67% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock